Phibro Animal Health reported higher first-quarter results for the period ended September 30, 2026, with net sales up 6% and net income up 11% from a year earlier. The company kept its fiscal 2027 guidance unchanged, and stockholders re-elected three Class I directors and ratified PricewaterhouseCoopers as auditor at the November 3, 2026 annual meeting.
Net sales of $386.8 million rose $22.9 million, or 6%, led by Mineral Nutrition, which rose 17%.
Net income of $29.5 million rose 11%, and diluted EPS of $0.72 rose $0.07 from $0.65.
Fiscal 2027 guidance was maintained: net sales of $1.55 billion to $1.60 billion and adjusted EBITDA of $258 million to $268 million.
At the November 3, 2026 annual meeting, all three director nominees were elected and PwC was ratified for the fiscal year ending June 30, 2027.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Phibro Animal Health's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2026
$1.52B
+17.1%
$2.43
+104.2%
6.6%
FY2025
$1.30B
+27.4%
$1.19
+1883.3%
3.7%
FY2024
$1.02B
+4.1%
$0.06
-92.6%
0.2%
FY2023
$977.89M
+3.8%
$0.81
-33.1%
3.3%
FY2022
$942.26M
+13.1%
$1.21
-9.7%
5.2%
Frequently asked questions
When is Phibro Animal Health's next earnings date?
Phibro Animal Health has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Phibro Animal Health earn last quarter?
For the quarter ended Sep 2026, Phibro Animal Health reported diluted EPS of $0.72 (+10.8% year over year) on revenue of $386.77M (+6.3%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.